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ABSTRACT 
A method to screen for jaundice in neonates using a digital 
image of the sclera is proposed.  e RGB pixel values from a 
raw format image are used to derive an estimate for the total 
serum bilirubin (TSB).  A study at UCH Neonatal Unit found a 
correlation of r=0.71 (p<0.01) between measured TSB and TSB 
estimated by this method.  e advantages of using a 
smartphone camera as a mobile screening device are discussed. 
1 BACKGROUND1 
Jaundice is caused by a build-up of bilirubin in the body, leading 
to a characteristic yellow discoloration of the skin and eyes.  It is 
very common in newborn babies, with 60% affected in the first 
week of life [1]. Although in many cases jaundice resolves 
spontaneously and without harm to the baby, if the bilirubin 
level in the blood is too high (a condition known as 
hyperbilirubinemia) there is a risk of brain damage.  Premature 
babies are more likely to become jaundiced (80% in the first week 
of life) and can be vulnerable to the neurotoxic effects of 
bilirubin at lower levels [1,2]. Once identified, jaundiced babies 
can be treated using phototherapy, or, in severe cases, exchange 
transfusion.  The diagnosis of jaundice is time-critical because 
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the longer hyperbilirubinemia remains untreated, the greater the 
risk of long-term neurological disability.  In addition, jaundice 
can be indicative of underlying illnesses that need urgent 
attention such as newborn hemolytic disease or sepsis [1]. 
The most accurate method for measuring the bilirubin level is 
via a blood test, which indicates the concentration of bilirubin in 
the blood, or total serum bilirubin (TSB).  However, it is neither 
practical nor desirable to take blood on a regular basis from all 
babies for the first weeks of their life, as the process is time-
consuming, expensive, painful for babies and distressing for new 
parents.  Babies are therefore screened for jaundice by neonatal 
nurses and midwives, who consider the apparent degree of 
yellow discoloration as well as factors such as gestational age 
and feeding behavior. Transcutaneous bilirubinometers (TcBs) 
can also be used. TcBs are placed directly in contact with the 
chest or forehead of the baby and measure the absorption of 
specific wavelengths of light to estimate the TSB. 
This project aims to establish a novel, contactless screening 
method. Recent advances in mobile phone technology allow 
access to the raw camera data. This opens the door to point-of-
care screening based on color measurement.  The method relies 
on a digital image to quantify the yellowness of the white of the 
eye (sclera) and thus the severity of the jaundice.  de Greef et al. 
have investigated using a smartphone to estimate the level of 
jaundice in newborns using a photograph of the skin alongside a 
custom color card [3]. In our work, the sclera is chosen because 
it is free from the melanin and hemoglobin chromophores found 
in skin, so its color provides a more direct indication of the TSB.  
(The conjunctiva covering the sclera also becomes yellow. Here 
we use “sclera” as a shorthand for “conjunctiva and sclera”.) 
A smartphone-based screening method has several potential 
advantages over existing screening techniques.  Visual 
assessment is inevitably subjective, and can be inaccurate and 




unreliable [4]. A measure based on a digital image of the sclera 
promises to be more consistent and objective.  This approach 
also has advantages over TcB screening.  As well as being an 
order of magnitude cheaper (a TcB costs approximately £3,400 
[1]), it would be contactless, which removes one possible avenue 
of infection for the vulnerable newborn.  Furthermore, TcBs are 
often unavailable in rural areas of less economically-developed 
countries.  In such areas, the greater number of home births and 
relative lack of contact with healthcare professionals leads to a 
higher burden of jaundice-related disability, as cases go 
untreated [5]. However, smartphones are increasingly 
commonplace in even the least technologically-advanced 
healthcare settings, meaning a smartphone-based screening 
method could have a significant impact in the early diagnosis of 
this time-critical condition. 
2 METHODS AND RESULTS 
A study has been conducted at the UCH Neonatal Unit to 
investigate the feasibility of using a digital image to screen for 
jaundice.  A Nikon D3200 camera in raw capture mode was used 
to photograph babies immediately before a blood sample was 
taken to measure TSB.  A 30x30 pixel region of interest (ROI) in 
the sclera was manually selected and the color information was 
used to derive a TSB estimate.  Figure 1 (Top) shows the 
correlation between the measured TSB and estimated TSB for 
the 86 subjects where a 30x30 ROI was visible. 
 
 
Figure 1. Top: Measured TSB vs Estimated TSB. Bottom: 
ROC curve for a screening threshold of 250 μmol/l. 
As a screening method, the key performance metrics are the 
sensitivity and specificity. The receiver operating characteristic 
(ROC) curve (Figure 1 (Bottom)) summarizes the performance of 
the estimation technique in correctly identifying babies with a 
TSB greater than 250µmol/l, which is the threshold above which 
babies ought to be referred for further tests per NICE guidelines 
[1]. For a sensitivity of 100%, a specificity of 60% can be 
achieved. This performance is at least as good as a TcB [6]. 
3 CONCLUSION AND FUTURE WORK 
Current work is focused on developing and testing an app to 
achieve these results using a smartphone camera.  Future 
implementations will include a method to discount the effect of 
the ambient light and automatically select an appropriate ROI. 
After light conditions, the most important source of variability 
when using a RGB camera as a measuring instrument is the 
spectral sensitivity.  The spectral sensitivity is the relative 
probability of the R, G or B sensor recording a count from an 
incident photon of given wavelength. Using the LED target 
described by MacDonald [7], three mobile phone cameras 
capable of capturing raw format images have been characterized.  
Further work is needed to quantify the degree to which the 
differences in their spectral sensitivities affect TSB estimation.   
In tandem, a public app is being developed to crowd source 
images of babies’ eyes.  It is hoped new mothers will use the app 
to track their babies’ jaundice with photographs and test results.  
Such a “jaundice diary” would help midwives by providing an 
overview of the jaundice progression.  It would also provide a 
rich database of pictures for the validation of future algorithms. 
By leveraging near-ubiquitous smartphone technology this 
screening method has the potential to empower parents and 
midwives to react sooner to jaundice and thus reduce the global 
burden of jaundice-related disability. 
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